Back to Trades
Schneider Eugene
EVPChf Clinical Develop OfcrCIK 0001838539
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 7
- Companies
- 1
- Active
- 2025–2026
Across 7 filings between 2025–2026, Schneider Eugene, EVP, Chf Clinical Develop Ofcr, has disclosed $12.2M in transactions — all concentrated in IONIS PHARMACEUTICALS INC (IONS). Their disclosed trades are heavily weighted toward selling — $0 in buys and $5.3M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 30 | IONS IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | $2.1M |
| Mar 23 | IONS IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | $412.5K |
| Feb 2 | IONS IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | $515.6K |
| Jan 20 | IONS IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | $703.1K |
| Jan 6 | IONS IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Award | $1.5M |
| Sep 4 | IONS IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | $1.2M |
| Aug 5 | IONS IONIS PHARMACEUTICALS INC | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | $408.7K |
7 filings